Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Biomarkers, Tumor / analysis*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / pathology*
• Female
• Gene Expression Profiling*
• Health Care Costs*
• Humans
• Practice Patterns, Physicians'*